Development of Multiple Sclerosis drugs

Development of Multiple Sclerosis drugs

FDA approved drug for an alternative indication, specifically Multiple Sclerosis.

Objective

Viclink is seeking investors to fund clinical trials

Unique Selling Propositions
  • New treatment for Multiple Sclerosis.
Applications
  • Multiple Sclerosis
IP Strategy

Patent filed

Project Status

Proof of Concept - Early prototype built